Shamburg News · 8-K filed Nov 18, 2026, 4:31 PM EST

Theriva Biologics Stockholders Approve Charter Amendment and Warrant Share Issuance at Special Meeting

TOVX · Theriva Biologics, Inc.

  • Shareholder vote
  • Materiality: low

On November 18, 2026, Theriva Biologics, Inc. held a special meeting of stockholders at which holders approved an amendment to increase authorized common stock to 500,000,000 shares, at the Board's discretion. Stockholders also ratified the issuance of up to 16,184,560 common shares upon exercise of warrants issued in the October 17, 2025 private placement. A proposal to adjourn the meeting was approved, but adjournment was not necessary because Proposals 1 and 2 received the requisite votes.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 5.07, accession 0001104659-26-129752.

Written from the filing by Shamburg Markets. Figures are as reported by the company.